Quick Answer
Pulmonx Corp reported Total Revenue of $90.50 million for fiscal year 2025.
Pulmonx Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $90.50M | +8.0% |
| 2024 | $83.79M | +22.0% |
| 2023 | $68.67M | +28.0% |
| 2022 | $53.66M | +10.8% |
| 2021 | $48.42M | +47.9% |
| 2020 | $32.73M | +0.4% |
| 2019 | $32.59M | +62.9% |
| 2018 | $20.00M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.50M | +5.5% | -9.9% |
| June 30, 2025 | $23.86M | +14.8% | +5.9% |
| March 31, 2025 | $22.54M | +19.5% | +10.6% |
| September 30, 2024 | $20.39M | +15.4% | -1.9% |
| June 30, 2024 | $20.78M | +20.9% | +10.2% |
| March 31, 2024 | $18.85M | +29.7% | +6.7% |
| September 30, 2023 | $17.67M | +30.9% | +2.8% |
| June 30, 2023 | $17.19M | +23.3% | +18.3% |
- Pulmonx Corp showed an increase of +8.0% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, Pulmonx Corp’s total revenue has grown by 352.4% (from $20.00 million to $90.50 million).
- The most recent figure is from Pulmonx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: